RANI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	477 354
Gjennomsnittsvolum	137 717
Markedsverdi	360.46M
EPS	$0 ( 2024-03-27 )
Neste inntjeningsdato	( $-0.230 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.38
ATR14	$0.0440 (0.62%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-21	Mckinley Kate	Buy	323 500	Stock Option (Right to Buy)
2024-03-21	Hashim Mir	Buy	323 500	Stock Option (Right to Buy)
2024-03-21	Groen Eric	Buy	323 500	Stock Option (Right to Buy)
2024-03-21	Imran Talat	Buy	1 085 000	Stock Option (Right to Buy)
2024-03-21	Sanford Svai S	Buy	323 500	Stock Option (Right to Buy)

INSIDER POWER
19.25
Last 99 transactions
Buy: 12 150 348 \| Sell: 8 157 844

Volum Korrelasjon

Lang: 0.02 (neutral)

Kort: 0.43 (neutral)

Signal:(53.823) Neutral

Rani Therapeutics Korrelasjon

10 Mest positive korrelasjoner
CATB	0.948
NYMX	0.94
ABIO	0.915
CADL	0.915
SGRP	0.912
AURC	0.911
MDIA	0.909
GRIN	0.908
CSTE	0.902
GALT	0.898

10 Mest negative korrelasjoner
YVR	-0.925
ARIZ	-0.921
ARVL	-0.904
ENNVU	-0.901
DUNE	-0.888
ACOR	-0.887
MBIO	-0.885
CASA	-0.883
CIIG	-0.875
ENVI	-0.872

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Rani Therapeutics Korrelasjon - Valuta/Råvare

-0.26
( neutral )

-0.47
( neutral )

0.00
( neutral )

-0.35
( neutral )

-0.45
( neutral )

0.40
( neutral )

Rani Therapeutics Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-822 000 (0.00 %)
EPS:	$-1.330

FY	2023
Omsetning:	$0
Bruttogevinst:	$-822 000 (0.00 %)
EPS:	$-1.330

FY	2022
Omsetning:	$0
Bruttogevinst:	$-1.31M (0.00 %)
EPS:	$-2.66

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.445

Financial Reports:

No articles found.

Rani Therapeutics

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

Sanntidsoppdatering for Rani Therapeutics [RANI]

Upcoming Earnings Alert